Intron A Solution For Injection 3000000iu Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Intron A: Solution for injection (3000000IU)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

INTERFERON ALFA-2b (in ter FEER on AL fa 2 b) is a man-made protein. Natural interferons are produced in the body to help the immune system fight viral infections and certain cancer growths. This medicine has similar actions to natural interferons and is used to treat AIDS-related Kaposi's sarcoma, certain types of hepatitis or certain cancers. This medicine may also be used to treat genital or perianal warts.

In-Depth Information

Intron A 18million unit Solution for Injection

NDC: 000851168
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hairy-cell Leukemia, St. Louis Encephalitis, Hepatitis B Infection, Malignant Melanoma, West Nile Virus Infection, Non-Hodgkin's Lymphoma (NHL), Hepatitis C Infection, Condylomata Acuminata, Kaposi's Sarcoma, Human Papillomavirus (HPV) Infection

Sometimes used for but not FDA approved for the following conditions:
Multiple Myeloma, Hypereosinophilic Syndrome, Hemangioma, T-cell Leukemia/lymphoma, Renal Cell Cancer, Chronic Myelogenous Leukemia (CML)

Storage Information
Avoid exposure to heat
Refrigerate (between 36 and 46 degrees F)
Do not refreeze
Intron A 18million unit Solution for Injection

Reported Side Effects for Intron A 18million unit Solution for Injection

Low Platelet Count Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Psychosis Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Breathing Difficulties Incidence:
<5.0%*
Severity: SEVERE
Onset: RAPID
Metallic Taste Incidence:
<50.0%*
Severity: MILD
Onset: EARLY
Emotional Lability Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
<21.0%*
Severity: MILD
Onset: DELAYED
Weight Loss Incidence:
<50.0%*
Severity: MILD
Onset: DELAYED
Hair Loss Incidence:
<50.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
<27.0%*
Severity: MODERATE
Onset: DELAYED
Nervousness Incidence:
<9.0%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
<13.0%*
Severity: MILD
Onset: DELAYED
Shortness Of Breath Incidence:
<34.0%*
Severity: MODERATE
Onset: EARLY
Hemolytic Anemia Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Hot Flashes Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Inability To Sleep Incidence:
<12.0%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
<34.0%*
Severity: MODERATE
Onset: DELAYED
Sinus Infection Incidence:
1.0-21.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
1.0-69.0%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
1.0-28.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
1.0-50.0%*
Severity: MILD
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
1.0-50.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
1.0-50.0%*
Severity: MILD
Onset: DELAYED
Thoughts Of Suicide Incidence:
1.0-3.0%*
Severity: SEVERE
Onset: DELAYED
Confusion Incidence:
1.0-8.0%*
Severity: MODERATE
Onset: EARLY
Diaphoresis Incidence:
1.0-21.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
2.0-50.0%*
Severity: MILD
Onset: EARLY
Convulsions Incidence:
>2.0%*
Severity: SEVERE
Onset: DELAYED
Heart Muscle Disease Incidence:
>2.0%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
2.0-50.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
3.0-14.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
3.0-40.0%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
3.0-19.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
5.0-63.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
7.0-50.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
8.0-96.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
16.0-75.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
18.0-66.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
21.0-62.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
34.0-94.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
45.0-54.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Intron A

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5